...
机译:贝伐单抗治疗恶性特征的回顾性研究
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Department of Neurosurgery Fujita Health University;
Brainstem; Glioma; Bevacizumab; VEGF; Malignant; Progression;
机译:贝伐单抗治疗恶性特征的回顾性研究
机译:回顾性分析评价贝伐单抗治疗复发性恶性胶质瘤的疗效和安全性
机译:贝伐单抗用于成人恶性脑干神经胶质瘤。
机译:光化学内在化治疗恶性胶质瘤
机译:开发用于治疗恶性神经胶质瘤的新型药物递送系统。
机译:贝伐单抗加伊立替康治疗复发性恶性脑胶质瘤和弥漫性脑干神经胶质瘤的儿童缺乏疗效:儿科脑肿瘤联合研究
机译:贝伐单抗加伊立替康治疗复发性恶性脑胶质瘤和弥漫性脑干神经胶质瘤的儿童缺乏疗效:儿科脑肿瘤联合研究